Evaluation of a 47Sc-labeled PDGFRβ-targeting affibody for SPECT imaging and radiotherapy applications in pancreatic cancer - Poll - MDSpire

Evaluation of a 47Sc-labeled PDGFRβ-targeting affibody for SPECT imaging and radiotherapy applications in pancreatic cancer

  • By

  • Ruomeng Liu

  • Dongping Su

  • Yuhao Liao

  • Zhao Li

  • Bo Li

  • Yunming Chen

  • Qi Cao

  • Jinsong Zhang

  • Huawei Cai

  • January 5, 2026

  • 0 min

Share

Original Source(s)

Evaluation of a 47Sc-labeled PDGFRβ-targeting affibody for SPECT imaging and radiotherapy applications in pancreatic cancer

  • by Ruomeng Liu, Dongping Su, Yuhao Liao, Zhao Li, Bo Li, Yunming Chen, Qi Cao, Jinsong Zhang, Huawei Cai

  • January 5, 2026

Related Content

Combination of Narrow-Margin Hepatectomy and External Beam Radiotherapy for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis

Who Decides When a Doctor Steps Back?

Cognitive decline, credentialing, and why “I’ll know” often isn’t enough.

Radiotherapy plus immunotherapy with or without chemotherapy improves survival in elderly esophageal squamous cell carcinoma: a real-world comorbidity-stratified study